Pharmacolog AB and HelioMetrics® Partner to Provide Critcal Drug Diversion Solutions

Collaboration Assures Essential Patient Safety with Behavioral
Analytics & Prevention of Drug Mismanagement as Leading Swedish
Innovator Expands into the United States

MINNEAPOLIS & UPPSALA, Sweden–(BUSINESS WIRE)–Pharmacolog AB and HelioMetrics today announced a new partnership that
will deliver solutions designed to stop drug diversion and provide safe
administration of IV medications for hospitals and pharmacies in the
United States. Headquartered in Sweden, this partnership will help
Pharmacolog expand into the U.S. market resulting in comprehensive drug
diversion programs with strategies to guarantee patient safety.

HelioMetrics is the industry’s leading drug diversion platform that
provides advanced data analytics that alarm against suspicious diversion
behavior and deviating drug prescribing patterns. Pharmacolog’s DrugLog®
is used to quickly screen the returns of opioids from the surgical ward
and can detect if the narcotic substance has been replaced or tampered
with. The measurement data from DrugLog is then collected by the data
analytics software resulting in an accurate summary of the drug’s
lifecycle.

“We are extremely happy to join forces with HelioMetrics,” said Mats
Högberg, CEO, Pharmacolog AB. “Their experience in drug diversion is
very valuable for us as we enter the U.S. market. There are several
companies developing data analytics software for drug diversion, but
HelioMetrics is the most reliable and comprehensive platform on the
market.”

“Our respective value propositions complement each other in the effort
to prevent drug diversion,” said Jeremy Wunsch, CEO, HelioMetrics, Inc.
“Pharmacolog’s DrugLog device can provide crucial data when screening
the returned narcotic substances, data that – when processed into
HelioMetrics advanced drug diversion analytics software – becomes vital
information in the efforts to prevent illicit use of controlled drugs in
healthcare.”

About Pharmacolog AB
Pharmacolog specializes in efficient
solutions to prevent medication errors and to simplify the
reconstitution and compounding process of medical drugs. Its advanced
DrugLog® device can determine a drugs identity and concentration in
seconds and therefore offers a unique method for quick and effective
screening in a Drug Diversion program. Headquartered in Uppsala Sweden,
please visit www.pharmacolog.com
for more information.

About HelioMetrics®
HelioMetrics is the industry’s
leading advanced drug diversion software platform. Its proprietary
Diversion Triangulation™ methodology, along with behavior
analytics, gives healthcare systems and pharmacies a closed loop process
for the precise monitoring, detection and investigation of drug
diversion while validating compliance to medication handling
policies. Headquartered in Minneapolis, Minn., please visit heliometrics.net
for more information.

Contacts

HelioMetrics
Cherie Mitchell
cmitchell@heliometrics.net
or
Pharmacolog
AB

Mats Högberg
mats.hogberg@pharmacolog.se